These drugs, which stimulate insulin release and reduce appetite, offer promising therapeutic options for managing blood sugar levels and supporting weight loss in individuals with these conditions
Mild nausea, if present, typically resolves within the first week
There are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy (see Clinical Considerations)
Compounded tirzepatide is not reviewed or approved by the FDA
Cosmetic product, 100% sterile, pharmaceutical quality
Obes Surg 33(4):10171025 Jamal M, Alhashemi M, Dsouza C et al (2024) Semaglutide and tirzepatide for the management of weight recurrence after sleeve gastrectomy: a retrospective cohort study